Role of the stevia and L-carnitine of a nutritional supplement on glycemic impact in adults

dc.contributor.authorAngarita Dávila, Lissé Chiquinquirá
dc.contributor.authorDurán Agüero, Samuel
dc.contributor.authorAparicio, Daniel
dc.contributor.authorParra, Karla
dc.contributor.authorUzcátegui, María
dc.contributor.authorCéspedes, Virginia
dc.contributor.authorReina Villasmil, Nadia
dc.contributor.authorLópez Miranda, José
dc.date.accessioned2024-09-05T16:26:38Z
dc.date.available2024-09-05T16:26:38Z
dc.date.issued2017
dc.descriptionIndexación: Scopus
dc.description.abstractCurrently the food industry has generated interest in non-nutritive sweeteners, for example Stevia and in special components such as L-carnitine, used in formulations of nutritional supplements for glycemic control specific for diabetics. The present study evaluated the effect of stevia and L-carnitine on the glycemic index (GI) and glycemic load (CG) of a nutritional supplement in 19 healthy subjects (9 men and 10 women), who randomly completed 3 consumption tests, 1 for the supplement and 1 for each reference product: Glucose solution (SG) and white bread (PB), obtaining blood samples at the 0, 15, 30, 45, 60, 90 and 120 min times; for measurement of blood glucose, basal and postprandial insulin. The increase area under the glucose curve (IAUC) was lower for supplement 11,778.73 than for reference products (SG) 13,724.06; (PB) 13,153.56 α = p 0.005. IG = (62) and CG = (16) were intermediate and lower than white bread IG = (69) and CG = (18), with no difference in postprandial insulin. This demonstrates that this nutritional supplement formulated with stevia and L-carnitine is able to prolong the glycemic response without increasing the insulin requirements in healthy subjects. Specific studies are required in diabetics to validate whether the glycemic impact is lower than the standard product. The presence of other nutrients in the formula, influential in these indicators, does not allow to infer that the results are due only to the type of sweetener used and the L-carnitine. © 2018, Grupo Aula Medica S.A. All rights reserved.
dc.description.urihttps://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S0212-16112017000900028
dc.identifier.citationNutricion Hospitalaria Volume 34, Issue 6, Pages 1455 - 14622017
dc.identifier.doi10.20960/nh.1153
dc.identifier.issn0212-1611
dc.identifier.urihttps://repositorio.unab.cl/handle/ria/59866
dc.language.isoes
dc.publisherGrupo Aula Medica S.A.
dc.rights.licenseAtribución/Reconocimiento-NoComercial-SinDerivados 4.0 Internacional CC BY-NC-ND 4.0 Deed
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.subjectGlycemia
dc.subjectL-carnitine
dc.subjectStevia
dc.subjectSupplement
dc.titleRole of the stevia and L-carnitine of a nutritional supplement on glycemic impact in adults
dc.title.alternative[Rol de la estevia y L-carnitina sobre el impacto glicémico de un suplemento nutricional en adultos]
dc.typeArtículo
Archivos
Bloque original
Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
TEXTO EN ESPAÑOL
Tamaño:
842.89 KB
Formato:
Adobe Portable Document Format
Bloque de licencias
Mostrando 1 - 1 de 1
No hay miniatura disponible
Nombre:
license.txt
Tamaño:
1.71 KB
Formato:
Item-specific license agreed upon to submission
Descripción: